Study: Pfizer vaccine protects against variants of coronavirus

About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel ...
Becker's Hospital Review

Pfizer Lyme vaccine candidate heads to FDA

Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to ...
Seeking Alpha

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above The investigational vaccine candidate was well tolerated ...

Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.

Pfizer seeking approval for Lyme disease vaccine

Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed for it. But help may soon be available. Pfizer is seeking approval for a ...
Wall Street Journal

Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval

An experimental Lyme disease vaccine from Pfizer PFE-0.70%decrease; red down pointing triangle and Valneva VLA-39.01%decrease; red down pointing triangle didn’t conclusively succeed in a large study, ...

pfizer vaccine

Find the latest pfizer vaccine news from Fast company. See related business and technology articles, photos, slideshows and ...